Improved detection and management of advanced HIV disease through a community adult TB‐contact tracing intervention with same‐day provision of the WHO‐recommended package of care including ART initiation in a rural district of Mozambique

AIDS‐mortality remains unacceptably high in sub‐Saharan Africa, largely driven by advanced HIV disease (AHD). We nested a study in an existing tuberculosis (TB) contact‐tracing intervention (Xpatial‐TB). The aim was to assess the burden of AHD among high‐risk people living with HIV (PLHIV) identified and to evaluate the provision of the WHO‐recommended package of care to this population.

[1]  H. Bygrave,et al.  Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives. , 2020, The lancet. HIV.

[2]  T. Ellman,et al.  Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening , 2020, PloS one.

[3]  Y. Fong,et al.  Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries , 2020, PloS one.

[4]  N. Kumarasamy,et al.  Advanced HIV: diagnosis, treatment, and prevention. , 2019, The lancet. HIV.

[5]  C. Heilig,et al.  Optimizing the efficiency of tuberculosis active case-finding in health facilities and communities. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  F. Tanser,et al.  The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure , 2019, bioRxiv.

[7]  A. Phillips,et al.  Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure , 2019, AIDS.

[8]  P. Drain,et al.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response , 2019, Clinical Microbiology Reviews.

[9]  S. Squire,et al.  Poor outcomes in recurrent tuberculosis: More than just drug resistance? , 2019, PloS one.

[10]  E. Casas,et al.  Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe , 2019, PloS one.

[11]  A. Garcia-Basteiro,et al.  High Yield of Home-Based TB Diagnosis Among Newly Diagnosed Patients With HIV. , 2019, Journal of acquired immune deficiency syndromes.

[12]  E. Szumilin,et al.  Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study , 2019, PLoS medicine.

[13]  D. Dowdy,et al.  Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB) , 2019, PLoS medicine.

[14]  S. Lawn,et al.  Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study , 2019, PLoS medicine.

[15]  M. Boffito,et al.  Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps , 2019, HIV medicine.

[16]  N. L. Oo,et al.  Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  Y. Manabe,et al.  Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities , 2018, Journal of acquired immune deficiency syndromes.

[18]  W. El-Sadr,et al.  Persons living with HIV with advanced HIV disease: need for novel care models , 2018, Journal of the International AIDS Society.

[19]  M. Muyoyeta,et al.  Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study , 2018, BMC Infectious Diseases.

[20]  V. Wiwanitkit,et al.  Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness , 2018, International journal of mycobacteriology.

[21]  S. Reynolds,et al.  Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV–tuberculosis co-infected adults with low CD4+ cell counts , 2018, AIDS.

[22]  I. Sinai,et al.  Improving management of tuberculosis in people living with HIV in South Africa through integration of HIV and tuberculosis services: a proof of concept study , 2018, BMC Health Services Research.

[23]  G. Rutherford,et al.  Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people , 2018, The Cochrane database of systematic reviews.

[24]  D. Naniche,et al.  Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention , 2018, Journal of acquired immune deficiency syndromes.

[25]  R. Chaisson,et al.  Yield of household contact tracing for tuberculosis in rural South Africa , 2018, BMC Infectious Diseases.

[26]  D. Denning,et al.  Estimated Burden of Serious Fungal Infections in Mozambique , 2018, Journal of fungi.

[27]  C. Ryan,et al.  Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection — Eswatini, 2015–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[28]  S. Lofgren,et al.  A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda , 2018, Journal of acquired immune deficiency syndromes.

[29]  T. Klimkait,et al.  Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial , 2018, JAMA.

[30]  T. Le.  World Health Organization Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy , 2018 .

[31]  E. Ochodo,et al.  Investigation of household contacts of pulmonary tuberculosis patients increases case detection in Mwanza City, Tanzania , 2018, BMC Infectious Diseases.

[32]  N. Ford,et al.  The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  N. Ford,et al.  Managing Advanced HIV Disease in a Public Health Approach , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  N. Ford,et al.  Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa’s National HIV Program: Data From a Nationwide Laboratory Cohort , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  James J. Lewis,et al.  Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa , 2018, PloS one.

[36]  H. Bygrave,et al.  Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe , 2018, PloS one.

[37]  N. Ford,et al.  Benefits and risks of rapid initiation of antiretroviral therapy , 2017, AIDS.

[38]  P. Drain,et al.  Point-of-care viral load testing and differentiated HIV care. , 2018, The lancet. HIV.

[39]  K. Dheda,et al.  Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer? , 2017, BMC Infectious Diseases.

[40]  S. Mancinelli,et al.  Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  S. Lawn,et al.  Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays , 2017, Scientific Reports.

[42]  D. Boulware,et al.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. , 2017, The Lancet. Infectious diseases.

[43]  Moyra J. Smith.  Point of Care Diagnostics , 2017 .

[44]  N. Ford,et al.  Evidence for scale up: the differentiated care research agenda , 2017, Journal of the International AIDS Society.

[45]  J. Pape,et al.  Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial , 2017, PLoS medicine.

[46]  H. Gesesew,et al.  Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015 , 2017, PloS one.

[47]  A. Kamali,et al.  Linkage to HIV care after home‐based HIV counselling and testing in sub‐Saharan Africa: a systematic review , 2017, Tropical medicine & international health : TM & IH.

[48]  S. Lawn,et al.  Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort , 2017, BMC Medicine.

[49]  F. Cobelens,et al.  Tuberculosis on the rise in southern Mozambique (1997–2012) , 2017, European Respiratory Journal.

[50]  J. Fehr,et al.  Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis , 2017, AIDS Research and Therapy.

[51]  S. Charalambous,et al.  Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa , 2016, PloS one.

[52]  Sikhulile Moyo,et al.  Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable , 2016, Journal of Clinical Microbiology.

[53]  B. Levin,et al.  Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care , 2016, PloS one.

[54]  M. Fox,et al.  Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa , 2016, PloS one.

[55]  J. Pfeiffer,et al.  Lessons learned and study results from HIVCore: an HIV implementation science initiative , 2016, Journal of the International AIDS Society.

[56]  Q. Bassat,et al.  Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012) , 2016, BMC Infectious Diseases.

[57]  Trevor Peter,et al.  POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis , 2016, PloS one.

[58]  M. Fox,et al.  Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial , 2016, PLoS medicine.

[59]  M. Lindegren,et al.  Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries , 2016, PloS one.

[60]  A. Harries,et al.  Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi , 2016, Journal of the International AIDS Society.

[61]  T. Bärnighausen,et al.  Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness , 2016, Journal of the International AIDS Society.

[62]  N. Ford,et al.  TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis , 2016, Journal of the International AIDS Society.

[63]  S. Lawn,et al.  Anemia, Blood Transfusion Requirements and Mortality Risk in Human Immunodeficiency Virus-Infected Adults Requiring Acute Medical Admission to Hospital in South Africa , 2015, Open forum infectious diseases.

[64]  I. Sanne,et al.  Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment , 2015, Southern African journal of HIV medicine.

[65]  S. Lawn,et al.  Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis , 2015, AIDS.

[66]  C. Menéndez,et al.  HIV Incidence and Spatial Clustering in a Rural Area of Southern Mozambique , 2015, PloS one.

[67]  A. Semeere,et al.  Implementation and Operational Research: Integrated Pre-Antiretroviral Therapy Screening and Treatment for Tuberculosis and Cryptococcal Antigenemia , 2015, Journal of acquired immune deficiency syndromes.

[68]  F. Cobelens,et al.  The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study , 2015, BMC Medicine.

[69]  J. Creswell,et al.  Comparative Meta-Analysis of Tuberculosis Contact Investigation Interventions in Eleven High Burden Countries , 2015, PloS one.

[70]  R. Collman,et al.  Persistent High Mortality in Advanced HIV/TB Despite Appropriate Antiretroviral and Antitubercular Therapy: an Emerging Challenge , 2015, Current HIV/AIDS Reports.

[71]  S. Vermund,et al.  Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique. , 2015, AIDS research and human retroviruses.

[72]  B. Shepherd,et al.  Patient Loss to Follow-Up Before Antiretroviral Therapy Initiation in Rural Mozambique , 2015, AIDS and Behavior.

[73]  J. Walter,et al.  High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique , 2014, Global health action.

[74]  M. Fox,et al.  Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough , 2013, AIDS research and treatment.

[75]  J. Golub,et al.  The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[76]  N. Nishikiori,et al.  Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning , 2013, BMC Public Health.

[77]  R. Chaisson,et al.  Undiagnosed Tuberculosis Among HIV Clinic Attendees: Association With Antiretroviral Therapy and Implications for Intensified Case Finding, Isoniazid Preventive Therapy, and Infection Control , 2012, Journal of acquired immune deficiency syndromes.

[78]  B. Marston,et al.  Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality Among Persons With Advanced HIV Infection Initiating Antiretroviral Therapy , 2012, Journal of acquired immune deficiency syndromes.

[79]  F. van Leth,et al.  Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy , 2011, Journal of acquired immune deficiency syndromes.

[80]  J. P. Ekwaru,et al.  Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda , 2007, Tropical medicine & international health : TM & IH.